Sign Up to like & get
recommendations!
1
Published in 2022 at "Current neuropharmacology"
DOI: 10.2174/1567202619999220209112609
Abstract: mGlu5 metabotropic glutamate receptors are considered as candidate drug targets in the treatment of "monogenic" forms of autism spectrum disorders (ASD), such as Fragile-X syndrome (FXS). However, despite promising preclinical data, clinical trials using mGlu5…
read more here.
Keywords:
idiopathic forms;
expression;
btbr mice;
mglu5 ... See more keywords